Kestra Advisory Services »

Sab Biotherapeutics shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2024-09-30 $32k 12k 2.70

More positions owned by Kestra Advisory Services

Apple (AAPL)
Parker-Hannifin Corporation (PH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)

View all positions for Kestra Advisory Services

Top funds holding Sab Biotherapeutics

BVF
Marshall Wace
Sessa Capital IM
Vanguard Group
HB Wealth Management
Geode Capital Management
Pathstone Holdings
First Manhattan
BlackRock
First PREMIER Bank
Kovitz Investment Group Partners
Institutional & Family Asset Management
BlackRock
Kestra Advisory Services
Citadel Advisors

View all funds holding Sab Biotherapeutics